• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pharmaids Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3844.0
  • ISIN : INE117D01018
66.09 0 (0.55%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    64.79

  • Today’s High

    68.90

  • Open

    66.00

  • Perv Close

    65.73

  • 52W Low

    31.90

  • 52W High

    87.46

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    233.08

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.09

  • Debt-Equity Ratio

    0.55

  • AGM Date

    25-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    233.08

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.27

  • BV (₹)

    18.10

  • Sales( ₹ in Cr.)

    2.34

  • NP (in Cr.)

    -7.28

  • NP Var(%)

    -47.0

  • Div%

    0.0

  • CPS (₹)

    -2.00

  • EPS (₹)

    -2.10

  • Traded Value (₹ in Lakhs)

    233.08

  • 52 Week High

    87.46

  • 52 Week Low

    31.90

  • Price BSE

    66.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    233.08

  • P/C Ratio

    -32.90

  • P/E Ratio

    -32.00

  • Price Vs.BV

    -2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.03 0.00 3.94 8.55 0.00 0.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.03 0.00 3.94 8.55 0.00 0.56
Other Income 0.80 0.00 0.02 0.03 0.00 0.01
Stock Adjustments 0.23 -0.89 0.52 0.37 0.00 0.00
Total Income 1.06 -0.89 4.48 8.95 0.00 0.57
EXPENDITURE :            
Raw Materials 0.25 0.00 4.09 8.53 0.00 0.36
Power and Fuel Cost 0.01 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.99 1.13 0.04 0.04 0.02 0.05
Other Manufacturing Expenses 0.04 0.02 0.00 0.00 0.01 0.00
Selling and Administration Expenses 1.45 0.80 0.19 0.23 0.23 0.20
Miscellaneous Expenses 2.88 7.06 0.00 0.01 0.07 0.06
Employee Benefit Expenses 1.99 1.13 0.04 0.04 0.02 0.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.62 9.00 4.32 8.82 0.34 0.67
Operating Profit -5.58 -9.89 0.15 0.13 -0.34 -0.10
Interest 0.33 0.00 0.00 0.00 0.00 0.00
Gross Profit -5.91 -9.89 0.15 0.13 -0.34 -0.10
Depreciation 0.18 0.02 0.01 0.04 0.04 0.05
Profit Before Tax -6.09 -9.91 0.14 0.09 -0.38 -0.15
Current Tax 0.00 0.00 0.00 0.00 0.00 0.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.14 -2.35 0.00 0.00 -0.41 0.00
Reported Net Profit -4.95 -7.56 0.15 0.09 0.03 -0.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.95 -7.56 0.15 0.09 0.03 -0.18
Adjustment below Net Profit -0.04 0.00 0.00 0.00 0.00 -0.01
P & L Balance brought forward -9.89 -2.33 -2.48 -2.57 -2.61 -2.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -14.88 -9.89 -2.33 -2.48 -2.57 -2.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.40 -3.52 0.14 0.09 0.03 0.00
Earnings Per Share(Adj)-Unit Curr -1.40 -3.52 0.14 0.09 0.03 0.00
Book Value 20.15 10.46 8.44 8.30 8.21 8.18
Book Value(Adj)-Unit Curr 20.15 10.46 8.44 8.30 8.21 8.18

Shareholding Pattern

  • Promoter Group

    5.14%

  • Public Share Holding

    94.86%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,813,174 5.14 1,813,174 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,813,174 5.14 1,813,174 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,679,392 4.76 1,678,392 18
Clearing Members 0 0.00 0 0
Directors of their Relatives 14,398,756 40.83 14,398,756 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 499,395 1.42 499,395 39
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,621 0.02 6,621 4
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,480,343 26.88 9,388,413 63
Individuals holding nominal share capital up to Rs. 1 lakh 3,338,721 9.47 2,450,520 7,818
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,130,612 3.21 1,130,612 3
Sub Total 33,454,638 94.86 32,473,507 8,013
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,267,812 100.00 34,286,681 8,026

Company Background

Pharmaids Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Pharmaids Pharmaceuticals Ltd
  • BSE Code : 3844.0
  • ISIN : INE117D01018

  • Incorporation Year

    1989

  • Registered Office

    4-4-211/212/3 1st Floor
    Inderbagh Sulthan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-66669809

  • FAX

    91-40-23232348

  • Chairman

    Shankarappa Nagaraja Vinaya Babu

  • Managing Director

  • Company Secretary

    Prasanna Subramanya Bhat.

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Pharmaids Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pharmaids Pharma 66.09 0.82 0.03 -32.08 0.00
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10